Natalie L Lanternier, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3056 River Crossing Court, Riverside, IA 52327 Phone: 319-467-8355 Fax: 319-467-8351 |
Dr. Elizabeth S Cramer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3056 River Crossing Ct, Riverside, IA 52327 Phone: 319-467-8355 Fax: 319-467-8351 |
Dr. David A Bedell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3056 River Crossing Court, Riverside, IA 52327 Phone: 319-467-8355 Fax: 319-467-8351 |
News Archive
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs-many of which have already been introduced into clinical practice-that permit higher overall survival rates and improvements in the quality of life of cancer patients.
Up to 30 patients with advanced incurable solid-tumours are to be involved in clinical trials of a potent new anticancer drug (CYT997), developed by Australian biotechnology company, Cytopia Limited.
The Ohio State University has signed an agreement with the Sarawak Biodiversity Centre in Malaysia to collaborate on the further development and commercialization of a promising anticancer agent derived from a tropical tree that grows on the island of Borneo.
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
A new consensus statement published in the September, 2010, issue of The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) finds that the increasing recognition that beta-cell failure occurs much earlier and severely than commonly believed suggests that regular glycemia screening, early identification of patients at metabolic risk and prompt and aggressive intervention deserves greater emphasis.
› Verified 6 days ago